Trial Details

RECRUITING
Basic Information
Clinical ID c365
Identifier NCT06710067
Trial Title Urine Metabolites in the Diagnosis of Disease
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Colorectal Cancer|Small Intestinal Bacterial Overgrowth Syndrome (SIBO)|Crohn Disease|Celiac Disease
Interventions -
Participant Information
Sponsor Luventix, Inc.
City Encinitas
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase NULL
Time Information
Start Date 2024-10-01
Primary Completion Date 2025-09
Completion Date 2026-09